Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included research that showed cancer surpassed cardiovascular disease to be the leading cause of death in high-income counties; HHS Secretary Alex Azar announced a new mandatory payment model is coming to oncology; a policy change could make mental health treatment more available.
You may need to log in to the website to access this podcast.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or through one of these podcast services:
Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties
Azar Announces Mandatory Oncology Payment Model Is Coming
HHS Lifting IMD Exclusion for Medicaid Payment for Inpatient Mental Health Treatment
Gallup-Sharecare Report Shows How Diabetes Ranks Grew Across the US
The American Journal of Managed Care—November 2018
Read more about the stories in this podcast:
Drug Overdoses Leading to Cardiac Arrest Rising, Particularly With Stimulant-Opioid Combination
November 25th 2023A population-based study found that out-of-hospital cardiac arrest events resulting from drug overdoses have significantly increased from 2015 to 2021, particularly among patients who have taken a combination of stimulants and opioids.
Read More
New Study Links Sphingolipids With Palmitic Acid to Increased Risk of Sudden Cardiac Death
November 17th 2023Plasma ceramides and sphingomyelins with palmitic acid were linked to a 34% and 37% increased risk of sudden cardiac death (SCD) per higher SD of log sphingolipid levels, respectively.
Read More
Rates of Elevated LDL-C Have Decreased, but Awareness, Treatment Still Suboptimal
November 6th 2023The prevalence of severely elevated low-density lipoprotein cholesterol (LDL-C) has declined in recent decades, but 1 in 17 US adults in a recent analysis had levels of LDL-C that would warrant consideration of pharmacotherapy, and 1 in 48 had high levels of LDL-C that are indicated for medication.
Read More